Malignant hepatic hilar obstruction
Conditions
Interventions
HIRZO stent
Sponsors
Osaka Medical College
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Over 20 years Malignant hepatic hilar obstruction with histological evidence Bismuth classification II, III, IV ECOG(Eastern Cooperative Oncology Group) performance status 0-3 Informed content
Exclusion criteria
Exclusion criteria: Inaccessible papilla Over ASA3 Over ECOG 4 Poor prognosis (3 months)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Technical feasibility | — |
Countries
Japan
Contacts
Public ContactTakeshi Ogura
Osaka Medical College 2nd Department of Internal Medicine
Outcome results
None listed